Cargando…
SARS Coronavirus and Lung Fibrosis
Severe acute respiratory syndrome (SARS) is an acute infectious disease with significant mortality. A novel coronavirus (SARS-CoV) has been shown to be the causative agent of SARS. The typical clinical feature associated with SARS is diffuse alveolar damage in lung, and lung fibrosis is evident in p...
Autores principales: | Zuo, Wei, Zhao, Xingang, Chen, Ye-Guang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7176214/ http://dx.doi.org/10.1007/978-3-642-03683-5_15 |
Ejemplares similares
-
Severe Acute Respiratory Syndrome-associated Coronavirus Nucleocapsid Protein Interacts with Smad3 and Modulates Transforming Growth Factor-β Signaling
por: Zhao, Xingang, et al.
Publicado: (2008) -
Lung transplantation as therapeutic option in acute respiratory distress syndrome for coronavirus disease 2019-related pulmonary fibrosis
por: Chen, Jing-Yu, et al.
Publicado: (2020) -
Fenofibrates: A Safe and Novel Weapon Against Coronavirus-Induced Lung Fibrosis
por: Namazi, Mohammad Reza, et al.
Publicado: (2022) -
Potential targets for anti-SARS drugs in the structural proteins from SARS related coronavirus
por: Wu, Guang, et al.
Publicado: (2004) -
The role of epidermal growth factor receptor (EGFR) signaling in SARS coronavirus-induced pulmonary fibrosis
por: Venkataraman, Thiagarajan, et al.
Publicado: (2017)